Zhu Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hematology top 5%
Papers in
-
- Circular RNAs in diseases 9
- Epigenetics and DNA Methylation 4
-
- Kidney Stones and Urolithiasis Treatments 9
- Prostate Cancer Treatment and Research 7
- Ferroptosis and cancer prognosis 6
- Co-authors
- Hui Liang (28 shared papers)Xiao Li (2 shared papers)Jianwen Zhang (9 shared papers)Hai‐Ning Chen (1 shared paper)Zong‐Guang Zhou (1 shared paper)Yuliang Wang (11 shared papers)Dinglan Wu (12 shared papers)Qiong Deng (9 shared papers)
- Journals
- Oncogene (6 papers)Cell Cycle (3 papers)Journal of Translational Medicine (3 papers)Frontiers in Oncology (3 papers)Stem Cell Research & Therapy (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Zhu Wang
168 papers receiving 3.1k citations
Zhu Wang's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 514
- Hematology 208
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 526
- Oncology 381
Countries citing papers authored by Zhu Wang
This map shows the geographic impact of Zhu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhu Wang more than expected).
Fields of papers citing papers by Zhu Wang
This network shows the impact of papers produced by Zhu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhu Wang. The network helps show where Zhu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 199 | |
| 2 | 2015 | 198 | |
| 3 | 2012 | 171 | |
| 4 | Recent advances on the mechanisms of kidney stone formation (Review) Hit paper breakdown → | 2021 | 170 |
| 5 | 2012 | 153 | |
| 6 | 2023 | 114 | |
| 7 | 2019 | 99 | |
| 8 | 2014 | 90 | |
| 9 | 2017 | 79 | |
| 10 | 2017 | 62 | |
| 11 | 2024 | 61 | |
| 12 | 2019 | 55 | |
| 13 | 2018 | 54 | |
| 14 | 2017 | 50 | |
| 15 | 2015 | 49 | |
| 16 | 2022 | 48 | |
| 17 | 2016 | 44 | |
| 18 | 2018 | 42 | |
| 19 | 2010 | 41 | |
| 20 | 2016 | 39 |
About Zhu Wang
Zhu Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 181 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (9 papers), Kidney Stones and Urolithiasis Treatments (9 papers), Prostate Cancer Treatment and Research (7 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Cells and Metastasis (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (514 citations), Hematology (208 citations), Molecular Biology (1.3k citations), Pulmonary and Respiratory Medicine (526 citations) and Oncology (381 citations). Zhu Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Hui Liang, Xiao Li, Jianwen Zhang, Hai‐Ning Chen, Zong‐Guang Zhou, Yuliang Wang, Dinglan Wu, Qiong Deng, Franky Leung Chan and Ying Zhang. Their work appears in journals such as Oncogene, Cell Cycle, Journal of Translational Medicine, Frontiers in Oncology and Stem Cell Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.